bioMerieux

France
Pharmaceuticals Biotechnology and Life Sciences

Risk Level:

Rating - Clear
Lower Risk

Summary:

bioMerieux is biotechnology company headquartered outside Lyon, France. bioMerieux does not provide viewpoint discrimination protections, though the company has not publicly terminated business relationships due to ideological differences. bioMerieux has not advocated for specific causes or policies, and the company has not funded ideological groups hostile to freedom of expression. For these reasons, bioMerieux receives a Lower Risk rating.

Criteria
Risk Level
Rationale
Corporate Weaponization
Criteria

Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level
Rationale

bioMerieux has not terminated business relationships due to ideological differences.

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level
Rationale

bioMerieux does not have a written rule discriminating against religious organizations in its philanthropy program (1).

Criteria

Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.

Risk Level
Rationale

bioMerieux does not provide viewpoint protections for employees (1).

Corporate Governance and Public Policy
Criteria

Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.

Risk Level
Rationale

bioMerieux has not corporately endorsed ideological causes or policies (1).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

bioMerieux has not corporately funded ideological groups hostile to freedom of expression (1).

Criteria

Uses corporate political contributions for ideological, non-business purposes.

Risk Level
Rationale

bioMerieux’s lobbying practices have been consistent with business interests (1).

All links were last accessed and all information was updated on:
March 24, 2023

Company reports are intended for educational use only. Full Disclaimer

Generate Reports
Clear
Toast